openPR Logo
Press release

Health Benefits of Hematologic Malignancies Therapeutics Market to Boost Global Demand by 2025 | Pfizer Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Celgene Corporation and Johnson & Johnson Services I

10-30-2018 01:49 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Hematologic Malignancies Therapeutics Market

Hematologic Malignancies Therapeutics Market

According to a recent study published by Polaris Market Research, the Hematologic Malignancies Therapeutics Market is anticipated to reach USD 87.0 Billion by 2025 from USD 40.4 Billion in 2017, growing at a CAGR of 10.11% during the forecast period.

Executive Summary: -

Hematologic malignancies are forms of cancer that initiate in the cells of the blood-forming tissue, such as in the cells of the immune system or the bone marrow. The cancer cell includes forms of myeloma, leukemia, and lymphoma. Growing global numbers of people suffering from leukemia and lymphoma are one of the major factors augmenting the Hematologic Malignancies Therapeutics Market growth.

According to leukemia and lymphoma society reports, an estimated combined total of 174,250 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2018. However, inventions of novel drugs for blood cancer and its regulatory approvals are expected to enhance the Hematologic Malignancies Therapeutics Market growth. In August 2017, Pfizer announced that the product - Besponsa (inotuzumab ozogamicin) has received USFDA approval for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Additionally, availability of products such as Imbruvica, Rituxan, and Glivec, which are estimated to be the highest revenue generating drugs, further boosting the market growth.

Get PDF for more Professional and Technical insights @
http://bit.ly/2QcJnjm

The major players operating in Hematologic Malignancies Therapeutics Market include: -

Pfizer, Inc.
F. Hoffmann-LA Roche ltd
Sanofi-Aventis
Bristol-Myers Squibb Company,
AbbVie Inc.
Novartis AG
GlaxoSmithKline PLC
Celgene Corporation
Johnson & Johnson Services Inc.
Takeda Pharmaceutical Company Limited.

The object of these key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.

Market Segmentation: -

Hematologic Malignancies Therapeutics Market is segmented on the basis of type, therapy, and geography. Depending upon the type, the market is segmented leukemia, lymphoma, multiple myeloma, and others. The leukemia is further segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Leukemia was estimated to dominate the market. The major market share is due to availability of products such as Imbruvica, Rituxan, and Glivec, which are estimated to be the highest revenue generating drugs.

For 'Queries' related to this research report, visit 'Inquiry Before Buy' @
http://bit.ly/2Q9EmZf

Geographic Analysis: -

On the basis of geography, North America is estimated to dominate the Hematologic Malignancies Therapeutics Market. The dominance is majorly attributed to the high presence of key market players, availability of branded drugs, established healthcare organization, and increasing government support in the region. However, Asia Pacific is expected to dominate the global Market during the forecast period. Increasing awareness about early diagnosis, availability of effective treatment in emerging countries, such as India and China is one of the major factors anticipated to remarkably boost the market growth in the Asia Pacific.

Key Take-away of Hematologic Malignancies Therapeutics Market: -

- Based on type, leukemia segment is estimated to dominate the market in 2017.
- Chemotherapy segment, to hold the dominating position for therapy type during the forecast period.
- North America holds major Hematologic Malignancies Therapeutics Market share by regional segment.
- In depth value chain analysis for product/therapy development and betterment during the forecast period.
- Leading edge market players, and their market winning strategies in the developing countries.
- Industry trends, that majorly focus on recent development and a drug/therapy pipeline that is effective for treating various types of cancer.

TOC of Hematologic Malignancies Therapeutics Market:

Chapter 1. Overview and Scope

Chapter 2. Market Summary

Chapter 3 Hematologic Malignancies Therapeutics Market Size and Forecast

Chapter 4. Dynamics and Segmentation

Chapter 5. Detailed Insight on Key Company

Chapter 6. Research Methodology and Reference

Chapter 7. Competitive Landscape

TOC Continuedโ€ฆ...!!!

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Health Benefits of Hematologic Malignancies Therapeutics Market to Boost Global Demand by 2025 | Pfizer Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Celgene Corporation and Johnson & Johnson Services I here

News-ID: 1339446 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Genetic Analysis Market Poised to Achieve USD 45.10 Billion by 2032, Growing at 8.60% Annually | Data By PMR
04-24-2024 | Health & Medicine
Polaris Market Research & Consulting
Genetic Analysis Market Poised to Achieve USD 45.10 Billion by 2032, Growing at โ€ฆ
๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ ๐ž๐ง๐ž๐ญ๐ข๐œ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ๐Ÿ.๐Ÿ‘๐Ÿ— ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ’๐Ÿ“.๐Ÿ๐ŸŽ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ–.๐Ÿ”๐ŸŽ% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐. The growing prevalence of early & rapid diagnosis and rising awareness of personalized medicines are the primary factors boosting the market growth. Besides, a significant rise in healthcare investments in major nationsโ€ฆ
Biobased Polyvinyl Chloride Market to Expand to US$ 3,488.72 Million by 2032, Reflecting a 18.70% CAGR from 2023 to 2032
04-24-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Biobased Polyvinyl Chloride Market to Expand to US$ 3,488.72 Million by 2032, Re โ€ฆ
The capacity to utilize renewable raw materials such as plant-dependent origin renders it an alluring option for industries seeking to assort their raw material origins, which is shaping the industry's future. Our thorough analysis of the Biobased Polyvinyl Chloride Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments. ๐”๐ง๐ฅ๐จ๐œ๐ค ๐จ๐ฎ๐ซ ๐„๐ฑ๐œ๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐“๐จ๐๐š๐ฒ: https://www.polarismarketresearch.com/industry-analysis/biobased-polyvinyl-chloride-market/request-for-sample ๐“๐ก๐ž ๐๐ข๐จ๐›๐š๐ฌ๐ž๐ ๐๐จ๐ฅ๐ฒ๐ฏ๐ข๐ง๐ฒ๐ฅโ€ฆ
Cell Dissociation Market Set to Surge to USD 1,161.06 Million by 2032, with Annual Growth Rate of 14.0% | PMR
04-24-2024 | Health & Medicine
Polaris Market Research & Consulting
Cell Dissociation Market Set to Surge to USD 1,161.06 Million by 2032, with Annu โ€ฆ
๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐œ๐ž๐ฅ๐ฅ ๐๐ข๐ฌ๐ฌ๐จ๐œ๐ข๐š๐ญ๐ข๐จ๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ‘๐Ÿ“๐Ÿ”.๐Ÿ•๐Ÿ” ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ,๐Ÿ๐Ÿ”๐Ÿ.๐ŸŽ๐Ÿ” ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ๐Ÿ’.๐ŸŽ% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐. Technological progressions, growing demand for cell-dependent assays and remedies, growing funding in research and development, and escalating approval of regenerative medicines are prominent trends shaping the industry's future. Our thorough analysis ofโ€ฆ
Surface Mount Technology Market Share Reach USD 10.00 Billion by 2032 | Growing at 8.30% CAGR
04-23-2024 | Business, Economy, Finances, B โ€ฆ
Polaris Market Research & Consulting
Surface Mount Technology Market Share Reach USD 10.00 Billion by 2032 | Growing โ€ฆ
๐“๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ฌ๐ญ๐ฎ๐๐ฒ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฏ๐ž๐š๐ฅ๐ฌ ๐ญ๐ก๐š๐ญ ๐ญ๐ก๐ž ๐’๐ฎ๐ซ๐Ÿ๐š๐œ๐ž ๐Œ๐จ๐ฎ๐ง๐ญ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฉ๐จ๐ข๐ฌ๐ž๐ ๐ญ๐จ ๐ฐ๐ข๐ญ๐ง๐ž๐ฌ๐ฌ ๐š ๐ฌ๐ญ๐ž๐š๐๐ฒ ๐œ๐จ๐ฆ๐ฉ๐จ๐ฎ๐ง๐ ๐š๐ง๐ง๐ฎ๐š๐ฅ ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐ซ๐š๐ญ๐ž (๐‚๐€๐†๐‘) ๐จ๐Ÿ 8.30% ๐จ๐ฏ๐ž๐ซ ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐ ๐Ÿ๐ซ๐จ๐ฆ 2024 ๐ญ๐จ 2032. ๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ 4.88 ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง 2023 ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐”๐’๐ƒ 10.00 ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ 2032. The growing trend of miniaturization in the electronics sector has led to increasedโ€ฆ

All 5 Releases


More Releases for Hematologic

07-11-2022 | Health & Medicine
Polaris Market Research & Consulting
Hematologic Malignancies Therapeutics Market Key Drivers, Restraints and Opportu โ€ฆ
Report Brief- Historical Data: 2018-2020 Base year: 2021 Current Year Data: 2022 Projected Data: 2022-2030 No. of Pages: 110+ Pages PDF Sample Report: Available on Request Hematologic Malignancies Therapeutics Market research report is indicating a significant growth rate and likely to be one of the industries that have been contributing to sustaining the international economy. Polaris Market Research recently published a research report on "Hematologic Malignancies Therapeutics Market [By Type (Leukemia (Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia,โ€ฆ
11-23-2021 | Advertising, Media Consulting, โ€ฆ
Statistify Market Research
Global Hematologic Malignancies Treatment Market 2021: Potential growth and oppo โ€ฆ
Market Overview This market report can aid them to make critical business decisions on production techniques, raw materials procurement, and to increase the industry chain cycle of the market worldwide. The case study report is a brief history and a deep evaluation of the Hematologic Malignancies Treatment market 2021 including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key company profiles, and overall competitive scenario. The research on theโ€ฆ
06-01-2020 | Health & Medicine
Marketinsightsreports
Hematologic Malignancies Market Developments, Competitive Analysis and Forecasts โ€ฆ
The global Hematologic Malignancies Market Research Report 2020-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data which enhances the understanding, scope and application of this report. (Specialโ€ฆ
10-07-2019 | Health & Medicine
Kenneth Research
Hematologic Malignancies Therapeutics Market-overview and scope, Industry Outloo โ€ฆ
The Global Hematologic Malignancies Therapeutics Market report provides an in-depth analysis of the Healthcare & Pharmaceuticals during the forecast period 2017-2025 which consists of the industry overview including the market size, volume, growth rate and recent trends and developments in the market based on historical and current data. The report covers detailed information about the key players, market segments, growth drivers and restraints in the industry. The report delivers anโ€ฆ
07-25-2018 | Health & Medicine
Ameri Research Inc.
Global Hematologic Malignancies Market Size, Analysis and forecast 2018 to 2025
The global Hematologic Malignancies market was valued at $42.8 Billion in 2017 and is forecast to grow at a modest XX.2 % CAGR between 2018 and 2025, culminating in 2025 global sales of $67.5 Billion. There are no definitive causes for hematologic malignancies. These cells in hematologic cancers arise from types of white blood cells: lymphocytes, granulocytes, and plasma cells. Approximately one in every 3 minutes diagnosed with a bloodโ€ฆ
12-26-2017 | Science & Education
QYresearchreports
Global Hematologic Malignancies Market Size, Competition by Manufacturers 2022
Qyresearchreports include new market research report "Global Hematologic Malignancies Market Size, Status and Forecast 2022" to its huge collection of research reports. The global Hematologic Malignancies market has been deeply evaluated in this publication with the help of both primary and secondary research and useful inputs provided by industry experts. The analysts who have prepared the publication have been among the best in the lot with sound understanding about almost allโ€ฆ